2.50
Hdl Handle:
http://hdl.handle.net/2336/2797
Title:
5-year incidence of age-related maculopathy in the Reykjavik Eye Study
Authors:
Jonasson, Fridbert; Arnarsson, Arsaell; Peto, Tunde; Sasaki, Hiroshi; Sasaki, Kazuyuki; Bird, Alan C
Citation:
Ophthalmology 2005, 112(1):132-8
Issue Date:
1-Jan-2005
Abstract:
PURPOSE: To examine the age- and gender-specific 5-year incidence of age-related maculopathy (ARM) and age-related macular degeneration (AMD) in citizens of Reykjavik. DESIGN: Population-based, prospective cohort study. PARTICIPANTS: The cohort was a population-based random sample of citizens 50 years and older. Of 1379 eligible subjects, 1045 had a baseline examination in 1996; 846 of the 958 survivors (88.2%) had a 5-year follow-up examination in 2001. METHODS: The incidence of various characteristics of drusen and pigmentary changes that are typical of ARM were determined using the international classification and grading system for ARM and AMD. MAIN OUTCOME MEASURES: Early ARM and AMD were assessed by masked grading of stereo fundus photographs. RESULTS: Hypopigmentation developed at 5 years in 10.7% of people 50 to 59 years of age (95% confidence interval [CI], 6.9-14.4) and in 25.7% those 70 to 79 years of age (95% CI, 18.4-33.0) at baseline. Age-related macular degeneration developed in no one who was 50 to 59 years of age at baseline. Geographic atrophy (GA) developed in 4.6% (95% CI, 1.2-7.9) and exudative AMD in none of those who were 70 years and older at baseline. CONCLUSIONS: Geographic atrophy is the predominant type of AMD in Iceland, and the ratio of GA to neovascular AMD is higher than in racially similar populations.
Description:
To access publisher full text version of this article. Please click on the hyperlink in Additional Links field
Additional Links:
http://www.sciencedirect.com/science/article/B6VT2-4DW8TFM-C/2/6f7ffff017416492ebcbd8d6b92e78cb

Full metadata record

DC FieldValue Language
dc.contributor.authorJonasson, Fridbert-
dc.contributor.authorArnarsson, Arsaell-
dc.contributor.authorPeto, Tunde-
dc.contributor.authorSasaki, Hiroshi-
dc.contributor.authorSasaki, Kazuyuki-
dc.contributor.authorBird, Alan C-
dc.date.accessioned2006-05-17T15:12:54Z-
dc.date.available2006-05-17T15:12:54Z-
dc.date.issued2005-01-01-
dc.identifier.citationOphthalmology 2005, 112(1):132-8en
dc.identifier.issn0161-6420-
dc.identifier.pmid15629833-
dc.identifier.doi10.1016/j.ophtha.2004.07.020-
dc.identifier.otherOPH12en
dc.identifier.urihttp://hdl.handle.net/2336/2797-
dc.descriptionTo access publisher full text version of this article. Please click on the hyperlink in Additional Links fielden
dc.description.abstractPURPOSE: To examine the age- and gender-specific 5-year incidence of age-related maculopathy (ARM) and age-related macular degeneration (AMD) in citizens of Reykjavik. DESIGN: Population-based, prospective cohort study. PARTICIPANTS: The cohort was a population-based random sample of citizens 50 years and older. Of 1379 eligible subjects, 1045 had a baseline examination in 1996; 846 of the 958 survivors (88.2%) had a 5-year follow-up examination in 2001. METHODS: The incidence of various characteristics of drusen and pigmentary changes that are typical of ARM were determined using the international classification and grading system for ARM and AMD. MAIN OUTCOME MEASURES: Early ARM and AMD were assessed by masked grading of stereo fundus photographs. RESULTS: Hypopigmentation developed at 5 years in 10.7% of people 50 to 59 years of age (95% confidence interval [CI], 6.9-14.4) and in 25.7% those 70 to 79 years of age (95% CI, 18.4-33.0) at baseline. Age-related macular degeneration developed in no one who was 50 to 59 years of age at baseline. Geographic atrophy (GA) developed in 4.6% (95% CI, 1.2-7.9) and exudative AMD in none of those who were 70 years and older at baseline. CONCLUSIONS: Geographic atrophy is the predominant type of AMD in Iceland, and the ratio of GA to neovascular AMD is higher than in racially similar populations.en
dc.language.isoenen
dc.publisherElsevieren
dc.relation.urlhttp://www.sciencedirect.com/science/article/B6VT2-4DW8TFM-C/2/6f7ffff017416492ebcbd8d6b92e78cben
dc.subject.meshResearch Support, Non-U.S. Gov'ten
dc.subject.meshMacular Degenerationen
dc.subject.meshSex Distributionen
dc.subject.meshAge Distributionen
dc.subject.meshAged, 80 and overen
dc.subject.meshMiddle Ageden
dc.subject.meshAgeden
dc.subject.meshIceland/epidemiologyen
dc.subject.meshMaleen
dc.subject.meshFemaleen
dc.subject.meshPopulation Surveillanceen
dc.subject.meshCohort Studiesen
dc.subject.meshProspective Studiesen
dc.title5-year incidence of age-related maculopathy in the Reykjavik Eye Studyen
dc.typeArticleen
dc.identifier.eissn1549-4713-
dc.identifier.journalOphthalmologyen
dc.format.digYES-

Related articles on PubMed

All Items in Hirsla are protected by copyright, with all rights reserved, unless otherwise indicated.